Celiac disease is triggered by a combination of genetic susceptibility, gluten exposure, and one or more environmental events that tip the immune system from tolerance into attack mode. About 1% to 2% of people in wheat-eating countries have the condition, but the majority of genetically at-risk individuals never develop it. That gap between risk and disease is where the real triggers live.
Genetics Set the Stage but Rarely Act Alone
Nearly all celiac patients, roughly 98%, carry one or both of two specific immune system gene variants called HLA-DQ2 and HLA-DQ8. These genes code for molecules on the surface of immune cells that present fragments of food proteins for inspection. In celiac disease, they happen to fit gluten fragments like a lock and key, which is what makes the immune reaction possible in the first place.
Here’s the critical point: about 40% of the general population carries one or both of these gene variants, yet only a small fraction ever develops celiac disease. Carrying HLA-DQ2 or DQ8 is necessary but nowhere near sufficient. Something else has to go wrong for the disease to actually switch on.
What Gluten Does Inside the Gut
When you eat wheat, barley, or rye, your digestive system breaks down most of the protein, but gluten is unusually resistant to digestion. Large fragments called gliadin peptides survive intact and reach the lining of the small intestine. In a person without celiac disease, these fragments pass through without incident. In someone with active celiac disease, a chain reaction begins.
First, gliadin triggers the gut lining to release a protein called zonulin, which loosens the tight junctions between intestinal cells. This opens gaps in the barrier, allowing undigested gliadin fragments to slip through into the tissue underneath. Once there, an enzyme called tissue transglutaminase chemically modifies the gliadin by converting certain amino acids into negatively charged forms. This modification is what makes the gliadin fragments bind snugly to HLA-DQ2 or DQ8 molecules on immune cells. The immune system then recognizes the modified gluten as a threat and launches an inflammatory attack on the intestinal lining itself.
Research at Columbia University has also identified non-gluten wheat proteins, including a group called serpins, that provoke an immune response in celiac patients. While gluten remains the primary driver, these additional proteins may intensify the inflammation.
Viral Infections Can Break Gluten Tolerance
One of the most significant discoveries in celiac research is that certain viral infections can destroy the gut’s ability to tolerate gluten. A landmark study published in Science showed that reovirus, a common and typically harmless intestinal virus, can reprogram the immune system’s response to dietary proteins.
In genetically susceptible mice, reovirus infection did two things simultaneously. It suppressed the regulatory immune cells that normally teach the body to ignore food proteins, and it activated inflammatory immune pathways against dietary gluten. The infection also triggered tissue transglutaminase activity in over 60% of infected mice, essentially jumpstarting the same enzyme process that modifies gluten in human celiac disease. The result was a loss of oral tolerance to gluten that persisted after the virus cleared.
This helps explain why celiac disease often appears after what seems like an unrelated illness. The virus itself may cause no memorable symptoms, but it can permanently alter how the immune system handles gluten.
Antibiotics and Gut Bacteria Shifts
The bacterial ecosystem in your gut plays a direct role in whether celiac disease activates. People with celiac disease consistently show higher levels of inflammatory bacteria like Bacteroides, Prevotella, and E. coli, alongside reduced levels of protective species like Bifidobacteria and Lactobacilli. Children at high genetic risk for celiac disease carry distinct bacterial profiles even before the disease appears, suggesting that gut bacteria may be a predisposing factor rather than just a consequence.
Antibiotics appear to accelerate this process. A study tracking children over time found that each course of antibiotics independently increased zonulin levels, the protein that controls intestinal permeability. Children who eventually developed celiac disease showed a significant rise in zonulin in the roughly 18 months before diagnosis, and antibiotic use amplified that rise. The proposed sequence: antibiotics disrupt the gut microbiome, the disrupted microbiome drives up zonulin, zonulin opens the intestinal barrier, and undigested gluten crosses into tissue where it triggers the immune cascade.
Stress and Major Life Events
Physiological and psychological stress can also serve as a trigger. In a study comparing 186 adults with celiac disease to 96 controls, celiac patients reported significantly more frequent life events in the years before diagnosis: 67% versus 38%. The most common categories were serious health problems (severe anemia, osteoporosis, thyroid disease) and loss of close family members.
Pregnancy stood out as a notable trigger. Over 20% of women with celiac disease described pregnancy as a negative health event preceding their diagnosis, compared to zero in the control group. Surgery and other forms of physical stress also appeared in patient histories. The pattern suggests that major physiological demands on the body can push a latent autoimmune process into full clinical expression, though the exact mechanism connecting stress to immune activation remains unclear.
When Gluten Is Introduced in Infancy
The timing of a child’s first exposure to gluten may influence celiac risk. A randomized trial of over 1,300 children in England and Wales compared early gluten introduction (starting around 4 months alongside breast milk or formula) to the standard approach of waiting until around 6 months. By age 3, seven children in the standard group had confirmed celiac disease (1.4%), while none in the early introduction group did.
The early group consumed about five times more gluten between ages 4 and 6 months than the standard group. The finding suggests that introducing small amounts of gluten while the infant immune system is still developing its tolerance mechanisms may offer some protection. Current evidence supports considering gluten introduction from 4 months onward, though this comes from a single trial and guidelines may evolve.
Why It Often Takes Multiple Triggers
Celiac disease rarely switches on from a single cause. The typical path involves a genetically susceptible person whose gut barrier becomes compromised through some combination of infection, antibiotic exposure, microbiome disruption, or physiological stress. Once the barrier opens and modified gluten fragments reach the immune system, the inflammatory response begins and, without removing gluten from the diet, sustains itself indefinitely.
This layered trigger model explains several puzzling features of the disease: why it can appear at any age, why identical twins don’t always share it, and why some people tolerate gluten for decades before suddenly developing symptoms. Each additional risk factor, from a course of antibiotics to a stressful pregnancy to a childhood virus, adds pressure to a system that was genetically primed but functionally stable. At some point, the balance tips.